30 related articles for article (PubMed ID: 27681755)
1. Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial.
Mantini G; Fersino S; Alitto AR; Frascino V; Massaccesi M; Fionda B; Iorio V; Luzi S; Balducci M; Mattiucci GC; Di Nardo F; De Belvis A; Morganti AG; Valentini V
Biomed Res Int; 2014; 2014():480725. PubMed ID: 25093169
[TBL] [Abstract][Full Text] [Related]
2. Prospective observational study evaluating acute and delayed treatment related toxicities of prophylactic extended field volumetric modulated arc therapy with concurrent cisplatin in cervical cancer patients with pelvic lymph node metastasis.
Ballari N; Rai B; Bahl A; Mittal BR; Ghoshal S
Tech Innov Patient Support Radiat Oncol; 2021 Mar; 17():48-56. PubMed ID: 33748442
[TBL] [Abstract][Full Text] [Related]
3. Intermediate-risk endometrial cancer treated with adjuvant brachytherapy using single dosimetric planning: long-term outcome and toxicity assessment.
Cordoba A; El Hajj H; Escande A; Scouarnec C; Narducci F; Martinez Gomez C; Leblanc E; Hudry D; Pasquesoone C; Taieb S; Mirabel X; Lartigau EF; Le Tinier F
Eur J Obstet Gynecol Reprod Biol; 2024 Apr; 298():23-30. PubMed ID: 38705010
[TBL] [Abstract][Full Text] [Related]
4. Modified simultaneous integrated boost radiotherapy for large retroperitoneal malignant tumor: A case report.
Nomiya T; Akamatsu H; Harada M; Ota I; Hagiwara Y; Ichikawa M; Miwa M; Mizutani M; Kato T; Nagaoka A; Tomita Y; Nemoto K
Oncol Lett; 2015 Jun; 9(6):2520-2524. PubMed ID: 26137100
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic body radiotherapy (SIB-VMAT technique) to dominant intraprostatic lesion (DIL) for localized prostate cancer: a dose-escalation trial (DESTROY-4).
Deodato F; Ferro M; Bonome P; Pezzulla D; Romano C; Buwenge M; Cilla S; Morganti AG; Macchia G
Strahlenther Onkol; 2024 Mar; 200(3):239-249. PubMed ID: 38180492
[TBL] [Abstract][Full Text] [Related]
6. Quality-of-Life Outcomes and Toxic Effects Among Patients With Cancers of the Uterus Treated With Stereotactic Pelvic Adjuvant Radiation Therapy: The SPARTACUS Phase 1/2 Nonrandomized Controlled Trial.
Leung E; Gladwish AP; Davidson M; Taggar A; Velker V; Barnes E; Mendez L; Donovan E; Gien LT; Covens A; Vicus D; Kupets R; MacKay H; Han K; Cheung P; Zhang L; Loblaw A; D'Souza DP
JAMA Oncol; 2022 Jun; 8(6):1-9. PubMed ID: 35420695
[TBL] [Abstract][Full Text] [Related]
7. Post-Operative Accelerated-Hypofractionated Chemoradiation With Volumetric Modulated Arc Therapy and Simultaneous Integrated Boost in Glioblastoma: A Phase I Study (ISIDE-BT-2).
Ferro M; Ferro M; Macchia G; Cilla S; Buwenge M; Re A; Romano C; Boccardi M; Picardi V; Cammelli S; Cucci E; Mignogna S; Di Lullo L; Valentini V; Morganti AG; Deodato F
Front Oncol; 2020; 10():626400. PubMed ID: 33692944
[TBL] [Abstract][Full Text] [Related]
8. Results of a Phase I-II Study on Laser Therapy for Vaginal Side Effects after Radiotherapy for Cancer of Uterine Cervix or Endometrium.
Perrone AM; Tesei M; Ferioli M; De Terlizzi F; Della Gatta AN; Boussedra S; Dondi G; Galuppi A; Morganti AG; De Iaco P
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32575821
[TBL] [Abstract][Full Text] [Related]
9. Radiation therapy for gynecologic malignancies during the COVID-19 pandemic: International expert consensus recommendations.
Elledge CR; Beriwal S; Chargari C; Chopra S; Erickson BA; Gaffney DK; Jhingran A; Klopp AH; Small W; Yashar CM; Viswanathan AN
Gynecol Oncol; 2020 Aug; 158(2):244-253. PubMed ID: 32563593
[TBL] [Abstract][Full Text] [Related]
10. Volumetric modulated arc therapy for treatment of solid tumors: current insights.
Macchia G; Deodato F; Cilla S; Cammelli S; Guido A; Ferioli M; Siepe G; Valentini V; Morganti AG; Ferrandina G
Onco Targets Ther; 2017; 10():3755-3772. PubMed ID: 28794640
[TBL] [Abstract][Full Text] [Related]
11. Volumetric-modulated arc therapy with vaginal cuff simultaneous integrated boost as an alternative to brachytherapy in adjuvant irradiation for endometrial cancer: a prospective study.
Alongi F; Mazzola R; Ricchetti F; Fersino S; Levra NG; Fiorentino A; Naccarato S; Sicignano G; Di Paola G; Ruggieri R; Gori S; Ceccaroni M
Anticancer Res; 2015 Apr; 35(4):2149-55. PubMed ID: 25862871
[TBL] [Abstract][Full Text] [Related]
12. Hypofractionation with simultaneous boost in breast cancer patients receiving adjuvant chemotherapy: A prospective evaluation of a case series and review of the literature.
De Rose F; Fogliata A; Franceschini D; Iftode C; Navarria P; Comito T; Franzese C; Fernandes B; Masci G; Torrisi R; Tinterri C; Testori A; Santoro A; Scorsetti M
Breast; 2018 Dec; 42():31-37. PubMed ID: 30149235
[TBL] [Abstract][Full Text] [Related]
13. Acute and long-term toxicity of whole pelvis proton radiation therapy for definitive or adjuvant management of gynecologic cancers.
Berlin E; Yegya-Raman N; Garver E; Li T; Lin LL; Taunk NK
Gynecol Oncol; 2023 May; 172():92-97. PubMed ID: 37003073
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous Integrated Boost Volumetric Modulated Arc Therapy in the Postoperative Treatment of High-Risk to Intermediate-Risk Endometrial Cancer: Results of ADA II Phase 1-2 Trial.
Macchia G; Cilla S; Deodato F; Ianiro A; Legge F; Marucci M; Cammelli S; Perrone AM; De Iaco P; Gambacorta MA; Autorino R; Valentini V; Morganti AG; Ferrandina G
Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):606-13. PubMed ID: 27681755
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison.
Macchia G; Cilla S; Morganti AG; Deodato F; Legge F; Piermattei A; Chiantera V; Scambia G; Valentini V; Ferrandina G
Acta Oncol; 2014 Feb; 53(2):251-8. PubMed ID: 24050516
[TBL] [Abstract][Full Text] [Related]
16. Radical hypo-fractionated radiotherapy with volumetric modulated arc therapy in lung cancer : A retrospective study of elderly patients with stage III disease.
Franceschini D; De Rose F; Cozzi L; Navarria P; Clerici E; Franzese C; Comito T; Tozzi A; Iftode C; D'Agostino G; Sorsetti M
Strahlenther Onkol; 2017 May; 193(5):385-391. PubMed ID: 28168322
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
